Recurrence of vitreous amyloidosis and need of surgical reintervention in portuguese patients with familial amyloidosis ATTR V30M

Retina

Volumn 31, Issue 7, 2011, Pages 1373-1377

  Beirão, Nuno Melo ^a   Matos, Eduarda ^b   Beirão, Idalina ^a,b   Costa, Paulo P ^a,c   Torres, Paulo ^a,b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH   (Portugal)

Author keywords

amyloid; familial amyloid polyneuropathy; familial amyloidosis ATTR V30M; FAP I; recurrence; transthyretin; vitrectomy; vitreous opacities

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; FAMILIAL AMYLOIDOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; PARAMETER; PORTUGAL; RECURRENT DISEASE; REOPERATION; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS AMYLOIDOSIS; VITREOUS BODY; VITREOUS DISEASE;

ADULT; AGED; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; PORTUGAL; PREALBUMIN; RECURRENCE; REOPERATION; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 79961208874     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318203c0c2     Document Type: Article

References (37)

1. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
2. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-888. (Pubitemid 14202671)
3. Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54-69. (Pubitemid 30317630)
4. Ong DE, Davis JT, O'Day WT, Bok D. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry 1994;33:1835-1842. (Pubitemid 24089713)
5. Buraczynska M, Mears AJ, Zareparsi S, et al. Gene expression profile of native human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2002;43:603-607. (Pubitemid 34184473)
6. Kawaji T, Ando Y, Nakamura M, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005;81: 306-312. (Pubitemid 41208165)
7. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295-298. (Pubitemid 27196759)
8. Monteiro JG, Martins AF, Figueira A, Saraiva MJ, Costa PP. Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities. Eye 1991;5:99-105.
9. Coutinho P, Silva AM, Lima LJ, et al. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: Glenner GG, Costa PP, Freitas AF, eds. Amyloid and Amyloidosis. Amsterdam, The Netherlands: Excerpta Medica; 1980:88-89.
10. Tsukahara S, Matsuo T. Secondary glaucoma accompanied with primary familial amyloidosis. Ophthalmologica 1977; 175:250-262. (Pubitemid 8186528)
11. Andersson R, Kassman T. Vitreous opacities in primary familial amyloidosis. Acta Ophthalmol (Copenh) 1968;46: 441-447.
12. Haraoka K, Ando Y, Ando E, et al. Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP). Amyloid 2002;9:183-189. (Pubitemid 35205208)
13. Kawaji T, Ando Y, Ando E, Nakamura M, Hirata A, Tanihara H. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy. Amyloid 2004;11:257-279.
14. Herbert J, Cavallaro T, Martone R. The distribution of retinolbinding protein and its mRNA in the rat eye. Invest Ophthalmol Vis Sci. 1991;32:302-309.
15. Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000; 7:266-269.
16. Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520-524.
17. Machemer R. A new concept for vitreous surgery. 2. Surgical technique and complications. Am J Ophthalmol 1972;74: 1022-1056.
18. Sandgren O, Stenkula S, Dedorsson I. Vitreous surgery in patients with primary neuropathic amyloidosis. Acta Ophthalmol (Copenh) 1985;63:383-388. (Pubitemid 15227393)
19. Chung SE, Kim KH, Kang SW. Retinal breaks associated with the induction of posterior vitreous detachment. Am J Ophthalmol 2009;147:1012-1016.
20. Lewis WD. Liver transplant and familial amyloidotic polyneuropathy. Liver Transpl. 2002;8:1085-1087.
21. Stangou AJ, Hawkins PN. Liver transplantation in transthyretin- related familial amyloid polyneuropathy. Curr Opin Neurol 2004;17:615-620. (Pubitemid 39410878)
22. Yamamoto S, Wilczek HE, Nowak G, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007;7:2597-2604. (Pubitemid 47561612)
23. Shimojima Y, Morita H, Kobayashi S, Takei Y, Ikeda S. Tenyear follow-up of peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation. J Neurol 2008;255:1220-1225.
24. Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy. Ann Intern Med 2001;135:931-932. (Pubitemid 33070695)
25. IrvineAR,Char DH.Recurrent amyloid involvement in the vitreous body after vitrectomy. Am J Ophthalmol 1976;82:705-708.
26. Doft BH, Machemer R, Skinner M, et al. Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology 1987;94:607-611. (Pubitemid 17085034)
27. Knapp CM, Sarodia U, Brown L, Bibby K. Primary nonfamilial ocular amyloidosis. Eye 2003;17:252-254.
28. Koga T, Ando E, Hirata A, et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188-193. (Pubitemid 36151796)
29. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173-196.
30. Missmahl H-P, Gafni J. Peri-collagen and peri-reticular amyloidoses. Their differentiation by polarization microscopy. Path Microbiol (Bazel) 1964;27:826.
31. Coimbra A, Andrade C. Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 1971;94:199-206.
32. Misumi Y, Ando Y, Ueda M, et al. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J Pathol 2009;219: 481-490.
33. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Ret Eye Res 2000;19: 323-344. (Pubitemid 30122726)
34. Swan DA. Chemistry and biology of the vitreous body. Int Rev Exp Pathol 1980;22:1-64.
35. StreetenBA.Disorders of the vitreous. InGarnerA,Klintworth GK, eds. Pathobiology of Ocular Disease-A Dynamic Approach, Part B. New York, NY: Marcel Dekker; 1982:1381-1419.
36. Quintas A, Saraiva MJM, Brito RMM. The tetrameric protein transthyretin dissociates to a non-native monomer in solution-a novel model for amyloidogenesis. J Biol Chem 1999;274: 32943-32949. (Pubitemid 129535333)
37. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596. (Pubitemid 36951371)